You have 9 free searches left this month | for more free features.

vay736

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in

Recruiting
  • Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
  • Columbus, Ohio
  • +9 more
Aug 1, 2022

Idiopathic Pulmonary Fibrosis Trial in Worldwide (VAY736, Placebo, Standard of Care (SoC))

Completed
  • Idiopathic Pulmonary Fibrosis
  • VAY736
  • +2 more
  • Birmingham, Alabama
  • +15 more
Sep 6, 2022

Primary Sjögren's Syndrome Trial in Berlin (VAY736, Placebo)

Completed
  • Primary Sjögren's Syndrome
  • VAY736
  • Placebo
  • Berlin, Germany
    Novartis Investigative Site
Sep 30, 2021

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)

Active, not recruiting
  • Systemic Lupus Erythematosus (SLE)
  • VAY736
  • +3 more
  • Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • +31 more
Sep 19, 2022

Pemphigus Vulgaris Trial in Worldwide (VAY736, Placebo)

Terminated
  • Pemphigus Vulgaris
  • VAY736
  • Placebo
  • Chapel Hill, North Carolina
  • +4 more
Oct 7, 2021

Relapse Remitting Multiple Sclerosis Trial in Czechia, Ukraine, United States (VAY736, Placebo)

Terminated
  • Relapse Remitting Multiple Sclerosis
  • VAY736
  • Placebo
  • Long Beach, California
  • +4 more
Dec 9, 2020

Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Trial in Tampa, Barcelona (VAY736)

Terminated
  • Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
  • VAY736
  • Tampa, Florida
  • +1 more
Feb 27, 2018